Heterocyclic nonacetamide ligands are used as positronemissiontomography (PET) imaging agents of the synaptic vesicle glycoprotein2A (SV2A), with potential applications in the diagnosis of variousneuropsychiatric diseases. The gene discussed is SV2A; the disease is glycogen storage disease VI.